[Edaily Marketin Reporter Soyoung Park ] This week (June 29–July 3), startups across various sectors—including medical imaging solutions, pre-owned luxury goods trading, AI entertainment, and bio-AI—secured investments from venture capital (VC) firms and accelerators (AC).

In particular, global video AI company “TwelveLabs” drew attention by successfully securing a $100 million (approximately 154.4 billion won) Series B investment. More than 90% of the world’s data is in video format. However, most of it is difficult to search and analyze, so it remains underutilized.

Investors highly valued the fact that TwelveLabs’ technology is being utilized across all industries. For example, the company has established a strong foothold in the media and entertainment sector. Recently, it has been expanding into the public sector by collaborating with government agencies worldwide. Adoption is also accelerating in industries where video search and analysis are essential, such as advertising, security, sports, and the automotive sector.

Global Video AI Company ‘Twelve Labs’

TwelveLabs, a global company building multimodal video understanding AI that comprehends and reasons about video content like a human, has completed a $100 million (approximately 154.4 billion won) Series B funding round. This round was co-led by NEA and Naver Ventures. Amazon participated as a major investor. In addition, existing investors such as Radical Ventures, Korea Investment Partners, and Index Ventures participated in the follow-on investment. Quadryl Capital and Red Bull Ventures joined as new investors. With this, the company’s total cumulative investment has reached over $200 million (approximately 308.7 billion won).

Building on this investment, Twelve Labs will move beyond the development of video understanding models to build a “Video Cognition System” that integrates perception, memory, and reasoning into a single architecture. The core of this system is an agent-based approach, where the system independently analyzes video, gathers evidence to draw inferences, and proceeds to make judgments and take actions.

Twelve Labs also plans to focus the funds from this investment on research and development (R&D) and global expansion. It will strengthen the capabilities of its offices in San Francisco, U.S., and Seoul, South Korea, and establish new offices in New York and London. The company intends to expand its global operational network, including Los Angeles (LA), to meet the demands of the corporate and public sectors worldwide.

The company is also expanding its business scope beyond the provision of foundation models and application programming interfaces (APIs) to include applications. Last month, Twelve Labs launched a closed beta service for “Rodeo,” an AI video creation tool, as its first application product. Rodeo is designed to help users easily search, analyze, and monetize large-scale video data. Video creators, operators, and decision-makers alike can utilize Twelve Labs’ video recognition system without the need for complex technical integration.

AI Medical Imaging Solution Company ‘AirsMedical’

Airs Medical, which provides imaging solutions to medical institutions, has secured follow-on investment from Dunamu & Partners. Global private equity firm TA Associates also participated in this round. The exact investment amount has not been disclosed.

AirsMedical offers the AI solution “SwiftMR.” It reduces MRI scan times by up to 50% while restoring low-quality MRI images to high quality. The company also provides “SwiftSite,” a platform for quantitative and structured MRI reporting. Through the company’s solutions, medical institutions can increase the utilization of existing equipment and expand their examination throughput. As a result, patients can undergo examinations in less time. More than 1,700 medical institutions in over 40 countries worldwide use the company’s solutions. The company is currently applying AI technology to more than 6 million examinations annually.

Recently, medical institutions have been adopting efficiency-focused operational strategies that prioritize maximizing the utilization of existing infrastructure over introducing new equipment. Consequently, demand for AI-based medical imaging solutions is also on the rise. Building on this investment, Airs Medical will strengthen its global market expansion and product competitiveness. The company will also work to advance its AI-based MRI solutions and develop new products.

Global Pre-Owned Luxury Goods Platform ‘Fapis’

Fapis, the operator of a platform specializing in the repair and resale of pre-owned luxury goods, has secured Series A bridge round funding from Smilegate Investment and SparkLabs. The investors highlighted the company’s dominance in the repair sector and its establishment of differentiated supply competitiveness. They also highly rated the company’s potential for global growth.

Fapis specializes in repairing pre-owned luxury goods, restoring them to the highest “S-grade” condition before selling them on consignment. This allows the company to offer sellers higher resale value and provide buyers with high-quality products at reasonable prices.

The company is focused on developing South Korea into the next-generation global luxury goods supply hub. It is establishing a structure to source luxury goods domestically and export them to Europe, Japan, the Middle East, and the United States. This strategy is supported by the company’s proprietary AI-based operational system. When a seller uploads a single photo, the AI automatically calculates the market price, determines authenticity, and estimates the expected return on investment after repair. The appraisal and pricing processes have been automated. The company has built a scalable operational structure where costs do not increase proportionally even as transaction volume grows.

AI Companion Startup ‘DeepGroove’

DeepGroove, which operates interactive AI story games where users become the protagonists, has secured 1.5 billion won in seed funding from Kakao Ventures and BonAngels Venture Partners. Kakao Ventures made the investment based on its assessment that the company has significant potential to grow into a new form of AI entertainment, thanks to its integrated structure that spans content creation to monetization.

DeepGroove creates new AI entertainment experiences based on a deep understanding of AI and users. The company has launched and is operating the AI story game “Frontia.” Frontia is an AI cinematic play-style story game where the narrative unfolds based on the user’s choices and dialogue. It combines various media elements—including voice, images, and video—to provide an immersive, interactive experience. The game is set in a variety of worlds, ranging from dating reality shows to disaster movies, fantasy adventures, and mysteries. Each user can experience a unique story and ending. Additionally, the company offers the “Frontia Studio Engine,” an AI-based production system that allows anyone to create and share their own content.

Based on this investment, DeepGroove plans to recruit key talent and accelerate product development. It also aims to evolve AI story games into a mainstream content platform accessible to a wider audience. The company also plans to begin its full-scale expansion into the global market.

Bio-AI Startup “Ampli”

Ampli, a bio-AI startup that diagnoses everyday health, has secured seed funding from Bluepoint Partners. The investment amount and company valuation remain undisclosed. Bluepoint took note of the company’s model, in which diagnostic results serve as the basis for consumer behavior. They view this as a distinctive competitive advantage that traditional consumer goods companies find difficult to secure. Bluepoint also expressed confidence that the company will establish a meaningful position in the wellness consumer goods market.

Ampli aims to build a “biochemical daily diagnostic platform” that simultaneously addresses the structural limitations of existing daily diagnostic solutions—low sensitivity, high costs, and inconvenient usability. The company has solved the problem of detecting low-concentration substances by applying the world’s first clip-type compression sampling method. At the core of this technology is “Triple-S,” a diagnostic technology based on Yonsei University’s nanobiotechnology research. Furthermore, through the “A-Cube” system—an ultra-high-sensitivity bio-AI diagnostic technology—and “Ampli Vision,” a deep learning-based quantitative analysis technology, the company achieves a reading accuracy of up to 99%.